|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Aug―30 |
Utility of plasma nucleocapsid protein in predicting severity and prognosis in severe COVID-19 patients with comorbidities |
Di Wang, Yutao Shen, Jianbo Wu, Yaju Li, Ke Ma, Guangjie Jiang, et al. (+5) Xiangyu Li, Huanhuan Qin, Kun Chen, Zhiyuan Wu, Ming Guan |
2 |
[GO] |
2024―Jul―20 |
Blood proteomics in COVID-19 infection: An update |
Michal Alexovič, Tetiana Bondarchuk, Csilla Uličná, Ján Sabo |
3 |
[GO] |
2024―May―15 |
Monitoring coronavirus disease progression and clinical impact through quantitative viral load testing |
Chih-Kai Chang, Chi-Sheng Chen, Ming-Jr Jian, Hsing-Yi Chung, Feng-Yee Chang, Jung-Chung Lin, et al. (+6) Shan-Shan Hsieh, Sheng-Hui Tang, Cherng-Lih Perng, Chien-Wen Chen, Chun-Hsiang Chiu, Hung-Sheng Shang |
4 |
[GO] |
2024―May―08 |
Comparison of changes in liver function tests in pregnant women with mild and severe COVID-19 |
R. Hosseiniara |
5 |
[GO] |
2024―May―08 |
Vitamin D and immune resilience in the context of COVID-19 |
A.H. Ghrieb |
6 |
[GO] |
2024―May―08 |
Characteristics of micronutrient intake in symptomatic and asymptomatic outpatients infected with COVID-19 |
L.E. Herrera-Jiménez, H.R. Ceja-Gálvez, J.F. Muñoz-Valle, C.J. Baños-Hernández, G. Macedo-Ojeda, G. González-Estevez |
7 |
[GO] |
2024―May―08 |
Drug-drug liver injury in patients NAFLD with COVID-19 |
A. Pavlov, A. Karakozov, A. Molodova, O. Denisova, S. Kazakov |
8 |
[GO] |
2024―May―08 |
Serum non-invasive liver fibrosis markers in patients with COVID-19 |
B. Cylwik, E. Gruszewska, B. Zelazowska-Rutkowska, M. Kazberuk, K. Gan, M. Kralisz, et al. (+2) A. Panasiuk, L. Chrostek |
9 |
[GO] |
2024―May―08 |
The study of the level of interleukin-6 and gamma interferon in patients with COVID-19 |
N. Davydova, S. Putkov, S. Kazakov |
10 |
[GO] |
2024―May―08 |
Laboratory indicators of inflammation in the development of cytokine storm in patients with COVID-19 |
S. Putkov, N. Davydova, S. Kazakov |
11 |
[GO] |
2024―May―08 |
Analysis of CD95 ligand on post COVID-19 patient: A novel approach to understand apoptosis role in long-term effect of COVID-19 |
M. Justyn, T. Yulianti, W. Gofarana |
12 |
[GO] |
2024―May―08 |
The connection of Vitamin D concentration with hematological parameters in patients with COVID-19 |
M. Stanojevic Pirkovic, T. Cvetkovic, I. Nikolic, M. Andjelkovic, S. Zivancevic Simonovic, B. Babovic, et al. (+7) J. Djordjevic, D. Jovanovic, J. Arsenijevic, D. Milovanovic, O. Gabric, M. Kostic, O. Mihaljevic |
13 |
[GO] |
2024―May―08 |
The connection of vitamin D with biomarkers of systemic inflammation in patients with COVID-19 |
O. Mihaljevic, S. Zivancevic Simonovic, V. Jurisic, B. Babovic, J. Djordjevic, D. Jovanovic, et al. (+3) J. Arsenijevic, D. Milovanovic, M. Stanojevic Pirkovic |
14 |
[GO] |
2024―May―08 |
The significance of hypovitamin D in the development of heart failure in patients with COVID-19 |
O. Mihaljevic, S. Zivancevic Simonovic, V. Jurisic, B. Babovic, J. Djordjevic, D. Jovanovic, et al. (+4) J. Arsenijevic, D. Milovanovic, O. Gabric, M. Stanojevic Pirkovic |
15 |
[GO] |
2024―May―08 |
The connection of hypovitaminose D and biomarkers of acute coronary syndrome in patients with COVID-19 |
M. Stanojevic Pirkovic, M. Andjelkovic, S. Zivancevic Simonovic, M. Petrovic, I. Nikolic, M. Kostic, et al. (+7) B. Babovic, J. Djordjevic, O. Gabric, J. Arsenijevic, D. Milovanovic, V. Jurisic, O. Mihaljevic |
16 |
[GO] |
2024―May―08 |
Distance changes of lymphocyte quantity and function in patients with COVID-19 |
S. Sołomacha, A. Moniuszko-Malinowska, P. Sowa, Ł. Kiszkiel, P. Laskowski, M. Alimowski, et al. (+2) Ł. Szczerbiński, K. Kamiński |
17 |
[GO] |
2024―May―08 |
Correlation of hepatocyte growth factor (HGF) and high sensitivity C-reactive protein (hs-CRP) in long-term COVID-19 |
B. Zaira, T. Yulianti, J. Levita |
18 |
[GO] |
2024―May―08 |
Serum galectin-9 concentration in patients with COVID-19 |
E. Gruszewska, M. Kralisz, B. Cylwik, M. Kazberuk, K. Gan, B. Mroczko, et al. (+2) A. Panasiuk, L. Chrostek |
19 |
[GO] |
2024―May―08 |
Procalcitonin and transferrin as a survival markers of patients with COVID-19 |
L. Chrostek, K. Gan, M. Kazberuk, M. Kralisz, E. Gruszewska, A. Panasiuk, B. Cylwik |
20 |
[GO] |
2024―May―08 |
Evaluation of laboratory parameters of hospitalized patients with COVID-19 |
C. Sgura, A.E. State, C. Cercel, S.G. Chiran, T.S. Holban, F. Romanoschi, et al. (+2) M. Vanghele, L.C. Mirzan |
21 |
[GO] |
2024―May―08 |
Interferon gamma and Interleukin 8 in COVID-19 |
F. Mechi, M. Ghozzi, S. Melayah, M. Taamalia, I. Ghedira |
22 |
[GO] |
2024―May―08 |
Kinetics of KL-6 may predict lung scarring after severe COVID-19 |
N. De Vos, M. Bruyneel, A. Roman, M. Antoine, F. Cotton |
23 |
[GO] |
2024―May―08 |
Spectrum of bacterial infection in COVID-19 and possibilities of antimicrobial therapy |
N. Esaulenko, O. Tkachenko, K. Komur, S. Kazakov |
24 |
[GO] |
2024―May―08 |
COVID-19 and susceptibility genes: A possible implication of the C-C type chemokine receptor 5 polymorphism |
R. Kerek, B. Alshaikh Khaled |
25 |
[GO] |
2024―May―08 |
Blood donation and seroprevalence of covid-19 antibodies among blood donors at central blood bank, Palestine |
R. Abu Seir, K. Yasin, L. Nazzal, O. Najjar |
26 |
[GO] |
2024―May―08 |
The emergence of SARS-COV-2 variant(s) and its impact on the prevalence of COVID-19 cases in the Nabatieh Region, Lebanon |
F.Y. Noureddine, M. Chakkour, A. El Roz, J. Reda, R. Al Sahily, A. Assi, et al. (+6) M. Joma, H. Salami, S.J. Hashem, B. Harb, G. Ghssein, A. Salami |
27 |
[GO] |
2024―May―08 |
Serologic profile of individuals who contracted COVID-19 despite triple vaccination |
S. El Hawat, P. Finianos, S. Yaacoub, M. Germanos Haddad, C. Haddad |
28 |
[GO] |
2024―May―08 |
Prevention of COVID-19 development in patients with hematological pathology receiving monoclonal antibody therapy |
E. Ignateva, O. Rukavitsyn, S. Kazakov |
29 |
[GO] |
2024―May―08 |
Identification of immunoreactive COVID-19 epitopes based on M13 phage display library |
T. Shabana, I. Abbasi, R. Abu Helu, H. Alkhatib |
30 |
[GO] |
2024―May―08 |
Clinical manifestations of rhinovirus infections during the latest wave of COVID-19 in hospitalized children |
O. Zaibi, Y. Maatouk, I. Baccouche, I. Handous, M. Marzouk, N. Hannachi, J. Boukadida |
31 |
[GO] |
2024―May―08 |
Alpha-defensins: Risk factor for thrombosis in COVID-19 infection |
S. Abdeen, R. Abu-Fanne, E. Maraga, N. Khurram, S. Samuel Heyman, D. Cines, A. Al-Roof Higazi |
32 |
[GO] |
2024―May―08 |
Persistence of T cell immunity responses against SARS-COV-2 for over 12 months post COVID-19 infection in unvaccinated convalescent individuals with no detectable IGG antibodies |
V. Pitiriga, M. Papamentzelopoulou, K. Konstantinakou, I. Vasileiou, K. Sakellariou, A. Tsakris |
33 |
[GO] |
2024―May―08 |
COVID-19 infection: a review of hematological and morphological features |
A.D. Amoroso, S. Bongo, S. Bernardini, G. Adorno, R. Massoud, M. Morello |
34 |
[GO] |
2024―May―08 |
GGT level as a new biomarker of COVID-19 infection; A systematic review and meta-analysis comparing intensive care unit(ICU) patients with non- ICU cases |
M. Tahani, S. Rakhshani Nasab, I. Shahramian, M. Afshari, H. Mirzaei, F. Parooie, M. Salarzaei |
35 |
[GO] |
2024―May―08 |
Mild-to-moderate COVID-19 may affect nervous system function in convalescents |
M. Lulek, M. Malecka-Gieldowska, O. Ciepiela |
36 |
[GO] |
2024―May―08 |
Epidemiological study: Evolution of septicemia deaths in Brazil (2017-2022) in the face of the COVID-19 Pandemic |
M. Danda Vasconcelos Santos, K. Silva Souza, M.R. Freire Da Silva, M. Almeida Candido, F. Motteran, L.C. Alexandre De Araújo, M.B. Melo De Oliveira |
37 |
[GO] |
2024―May―08 |
Assessment of d-dimer concentrations determined in outpatients in a selected medical laboratory during the covid-19 pandemic (2020-2022) |
S. Myslicki, P. Cembrowska, J. Sikora |
38 |
[GO] |
2024―May―08 |
How did the COVID-19 pandemic impact drug trends? |
G. García De La Rosa, R. Pérez Rodríguez, C. Frías Ruiz, C. Burruezo Rodríguez, S. De Las Heras Flórez |
39 |
[GO] |
2024―May―08 |
The essential role of volunteer biologists in Lebanon’s COVID-19 pandemic management efforts |
M. Germanos, N. Banna, Z. Berjaoui, N. Bizri, P. Finianos, H. Hassan, et al. (+7) W. Hassan, E. Khoury, M. Nabulsi, A. Sabbah, S. Samad, S. Talhouk, C. Haddad |
40 |
[GO] |
2024―May―08 |
Oxidative stress severity’s as a hallmark in the COVID-19 patients |
A.H. Doustimotlagh, N. Roustaei, M. Eftekhari, A. Bastin |
41 |
[GO] |
2024―May―08 |
Significance of leukogram-derived indices (NLR, LMR and NER) in the monitoring of COVID-19 patients |
L. Halilovic, E. Begovic, E. Sehercehajic, B. Hasanefendic, S. Hajro, S. Muhovic, et al. (+2) E. Hajrovic Hebibovic, A. Asotic Memic |
42 |
[GO] |
2024―May―08 |
Correlation of specific inlammatory and coagulation parameters among COVID-19 patients |
B. Hasanefendic, A. Husic-Selimovic, E. Sehercehajic, L. Halilovic, S. Tihic-Kapidzic, J. Foco-Solak, et al. (+2) V. Smajlbegovic, L. Ibricevic-Balic |
43 |
[GO] |
2024―May―08 |
Growth differentiation factor 15 (GDF-15) as a predictor of mortality in COVID-19 patients |
S. Mandić, L. Švitek, I. Lukić, T. Rolić, B. Grubišić, M. Zlosa, Z. Todorić |
44 |
[GO] |
2024―May―08 |
Rotational thromboelastometry (CLORPRO) profiling of COVID-19 patients |
I. Rodriguez Martin, J. Montenegro Martínez, J.L. Rubio Prieto, J.M. Guerrero MontÁvez |
45 |
[GO] |
2024―May―08 |
The biomarkers of oxidative stress - An effective tool for diagnosing COVID-19 patients and convalescents |
B. Wolszczak-Biedrzycka, J. Dorf, J. Matowicka-Karna, M. Wojewódzka-Żeleźniakowicz, A. Zalewska, M. Maciejczyk |
46 |
[GO] |
2024―May―08 |
Prevalence of serum TnI elevation among COVID-19 patients at Kenyatta National Hospital, Kenya |
T. Kaugiria, A. Amayo, M. Mungania |
47 |
[GO] |
2024―May―08 |
Prevalence of serum TnI elevation among COVID-19 patients at KNH, Kenya |
A. Kaugiria |
48 |
[GO] |
2024―May―08 |
Superinfections in COVID-19 patients hospitalized in intensive care unit (ICU): Risk factors and mortality |
Z. Hammami, Y. Ben Lamine, S. Kaoual, O. Nasri, A. Trabelsi, O. Kaabachi, S. Bebes |
49 |
[GO] |
2024―May―08 |
Prediction of atherosclerosis in severe COVID-19 patients with CD16 and CD18 markers and inflammatory factors |
R. Mardani, M. Shahali |
50 |
[GO] |
2024―May―08 |
IVDR performance study of angiotensine-1-7, TGF-beta and KL-6 for COVID-19 sequela |
N. De Vos, M. Antoine, M. Bruyneel, A. Roman, F. Cotton |
51 |
[GO] |
2024―May―08 |
Predictive value of ferritin, IL-6, and erythropoietin in assessment of COVID-19 severity |
K. Gugo, L. Rumora, M. Pavicic Ivelja, L. Tandara |
52 |
[GO] |
2024―May―08 |
Interleukin 8 but not interferon gamma is predictive of COVID-19 severity: A tunisian study |
F. Mechi, M. Ghozzi, S. Melayah, M. Taamalia, I. Ghedira |
53 |
[GO] |
2024―May―08 |
Machine learning-based prediction of intensive care during hospitalization for COVID-19 using laboratory test results at admission |
H. Lame, E. Refatllari, N. Heta, I. Korita, A. Coraj, V. Tole, A. Bulo |
54 |
[GO] |
2024―May―08 |
Prospective evaluation of the likelihood of vaxzevria-induced thrombosis among nigerian healthcare workers undergoing COVID-19 vaccination |
C. Amadi, D.L. Stephenson |
55 |
[GO] |
2024―May―08 |
Vaccine uptake, barriers and enhancers of COVID-19 vaccination among health care workers in Ethiopia |
G. Bulti, D. Asfaw, S. Abdella, J. Bulti Tura, Y. Wondarad, G. Fetensa, et al. (+14) T. Gelanew, A. Abdissa, S. Sembuche, S. Gonese, M. Fallah, R. Tajudeen, S. Nakasendwa, R. Ayebare, L. Mbabazi, A. Kiragga, F. Kakooza, M. Hailu, G. Tollera, A. Tsegaye |
56 |
[GO] |
2024―May―08 |
Two years after MRNA COVID-19 vaccination anti-spike SARS-COV-2 antibodies persist at high concentrations, due to boosters administration and natural contact with the virus |
J. Swadzba, T. Anyszek, E. Martin, A. Panek |
57 |
[GO] |
2024―May―08 |
Unraveling the impact of COVID-19 vaccination on hospital stay, ICU admission and mortality: A real world evidence from Pakistan |
N. Afzal |
58 |
[GO] |
2024―May―08 |
Assessment of COVID-19 vaccine immunogenicity over one year in patients receiving immunomodulators/immunosuppressants or polychemotherapy |
S. Kouara, Z. Lebbar, K. Meliani, G. Yahyaoui, Z. Khammar, R. Berrady, M. Mahmoud |
59 |
[GO] |
2024―May―08 |
Public perception towards the COVID-19 vaccine in Riyadh, Saudi Arabia |
Z. Kurdee, S. Al-Shouli, N. Alafaleq, S. Ayoub Meo, A. Alshahrani, A. Alshehri, et al. (+3) N. Alkathiri, S. Bin Saiedan, Y. Alzahrani |
60 |
[GO] |
2024―May―08 |
Calprotectin as a novel indicator of severe COVID-19: A cross-sectional study in Mexican population |
H.R. Ceja-Galvez, C.O. Hernández Ramírez, A.N. Vega-Magaña, K.J. Arellano-Arteaga, E. Miramontes-Luna, F.J. Turrubiates- Hernandez, et al. (+2) D.L. Padilla-Borquez, J.F. Muñoz-Valle |
61 |
[GO] |
2024―May―08 |
Depletion of retinol-binding protein 4 levels in hospitalized patients with COVID-19: A potential biomarker for disease severity |
F.J. Turrubiates-Hernández, G. Muñoz-Ríos, C.O. Hernández-Ramírez, H.R. Ceja-Gálvez, S. García-Arellano, L.E. Herrera-Jiménez, et al. (+3) G. González-Estevez, K.J. Arellano-Arteaga, J.F. Muñoz-Valle |
62 |
[GO] |
2024―May―08 |
Clinical performance evaluation of smartchek SARS-COV-2 detection kit and smartchek SARS-COV-2 fast detection kit for detection of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) in saliva |
M.J. Kim, S. Yoon, S.R. Cho |
63 |
[GO] |
2024―May―08 |
Point of care testing for new coronavirus antigen detection (SARS-COV-2): A Critical analysis of instructions for use and degree of agreement compared to RT-PCR |
B. Gonçalves Carneiro, L. Vasconcellos |
64 |
[GO] |
2024―May―08 |
The relationship between disorders of the plasma and platelet components of hemostasis with the severity and timing of coronavirus infection in patients with chronic coronary syndromes |
V. Sujayeva, I. Karpova, M. Kolyadko, O. Koshlataya, I. Russkich |
65 |
[GO] |
2024―May―08 |
One-pot isothermal amplification and CRISPR-CAS12A assay for rapid detection of SARS-COV-2 |
S. Tang, S. Qian, H. Lin, B. Li, X. Deng, H. Chen |
66 |
[GO] |
2024―May―08 |
Detection and comparison of SARS-COV-2 antibody produced in naturally infected and vaccinated patients in Addis Ababa, Ethiopia |
C. Bashea, F. Challa, T. Lejisa, S. Ali, G.B. Hundie, H.H. Tola, et al. (+2) A. Gize, W. Tsegaye |
67 |
[GO] |
2024―May―08 |
Evaluation of the diagnostic performance of the sofia 2 SARS CoV2 system in the detection of SARS-CoV-2 antigen in POCT: An analysis of 130 samples |
V. Lombari, E. Esposito, V. Proietti, S. Sgueglia, L.A. Catapane, A. Terracciano, et al. (+3) L. Sorione, G. Loquercio, A. Petruzziello |
68 |
[GO] |
2024―May―08 |
Humoral and cellular immune responses in fully vaccinated individuals with or without SARS-COV-2 breakthrough infection: Results from the cov-adapt cohort |
M. Schnelle, S. Dierks, M. Hollstein, M. Schön, U. Groß, A. Kröger, et al. (+3) A. Zautner, A. Fischer, L. Erpenbeck |
69 |
[GO] |
2024―May―08 |
Circulating CD4+ T lymphocyte helper cells confer protection to reinfection of SARS-COV-2 but not circulating CD8+ T Lymphocyte natural killer cells |
J. Donnelly, L. Abdelwareth, F. Al Hosani, R. Abuyadek, R. Al-Rifia, S. Atef |
70 |
[GO] |
2024―May―08 |
The increased sensitivity of the Xpert® Xpress assay in detecting SARS-COV-2, compared to the COBAS® assay, can be attributed to the nucleocapsid gene target |
B. Ayano, A. Alemu, S. Gebre-Selassie, H. Kebede, W. Abegaz |
71 |
[GO] |
2024―May―08 |
AI unravels dual-targeting mechanism: Crafting potential inhibitors for SARS-CoV-2 design |
R. Hamdy |
72 |
[GO] |
2024―May―08 |
Optimization between reagent use efficiency and analytical sensitivity for a reliable pool-based strategy of SARS-COV-2 detection |
J.P. Miranda, J. Osorio, M. Silva, C. Silva, M. Henríquez-Henríquez |
73 |
[GO] |
2024―May―08 |
Results of the external quality assessment (EQA) scheme for serological diagnostic test for SARS-CoV-2 detection in Sicily region (Italy), in 2020-2022 |
F. Di Gaudio, G. Brunacci, O. Aiello, V. Buffa, V. Orlando, F. Centineo, et al. (+5) A. Lundari, A. Cancilleri, F. Napoli, G. Rinaudo, A. Cucina |
74 |
[GO] |
2024―May―08 |
Follow-up and comparative assessment of SARS-COV-2 IGA, IGG, neutralizing, and total antibody responses after BNT162B2 or MRNA-1273 heterologous booster vaccination |
S. Younes, E. Nicolai, M. Pieri, B. Sergio, H.I. Daas, D.W. Al-Sadeq, et al. (+9) N. Younes, F.M. Shurrab, P. Nizamuddin, F. Humaira, N. Al-Dewik, H.M. Yassine, L.J. Abu-Raddad, A. Ismail, G. Nasrallah |
75 |
[GO] |
2024―May―08 |
Assessment of humoral and cellular immunity to SARS-COV-2 in end-stage renal disease patients treated with haemodialysis |
D. Cujic, A. Todorovic, M. Gnjatovic, E. Jordanova, M. Stajcic, R. Markovic, T. Jemcov |
76 |
[GO] |
2024―May―08 |
Machine learning algorithms for identification of SARS-CoV-2 in neonates |
D. Dobrijević, J. Katanić, K. Pastor |
77 |
[GO] |
2024―May―08 |
The association between polymorphisms of ACE1, ACE2, IFTM3, TMPRSS2 AND TNF< genes with susceptibility and severity of SARS-COV-2 infection |
V. Pecoraro, M. Cuccorese, T. Trenti |
78 |
[GO] |
2024―May―08 |
In silico screening of potential SARS-COV-2 MAIN protease inhibitors from thymus Schimperi |
H.M. Mengist, K. Zunera, A. Fentahun |
79 |
[GO] |
2024―May―08 |
Quality and composition of archived nucleic acids after use in SARS-COV-2 molecular testing |
J.W. Shin, J. Kim, H.H. Song, J.C. Choi, R. Lee, S.K. Yoon, et al. (+2) H.J. Park, Y.H. Shin |
80 |
[GO] |
2024―May―08 |
Performance of novel SARS-COV-2 rapid antigen tests during omicron outbreak compared with Omicron RT-PCR and whole-genome sequencing |
S. Kim, W. Choi |
81 |
[GO] |
2024―May―08 |
Stable preservation of SARS-COV-2 RNA from gargle samples on FTA cards |
G. Kriegshäuser, A. Berndt, D. Alpar, C. Oberkanins |
82 |
[GO] |
2024―May―08 |
SARS-COV-2 seroprevalence and risk factors associated with infection in adults from western Romania, January to March 2023 |
T.R. Olariu, A.C. Craciun, D.C. Vlad, V. Dumitrascu, M.A. Lupu |
83 |
[GO] |
2024―May―08 |
Enhancing the sensitivity of rapid antigen detection test (RADT) of different SARS-COV-2 variants and lineages using fluorescence-labeled antibodies and a fluorescent meter |
G. Nasrallah, F. Ali, S. Younes, H.M. Yassine |
84 |
[GO] |
2024―May―08 |
Persistence of SARS-COV-2-specific T cell responses for over 12 months in vaccinated population with no measurable levels of anti-S antibodies |
V. Pitiriga, M. Papamentzelopoulou, K. Konstantinakou, I. Vasileiou, A. Tsakris |
85 |
[GO] |
2024―May―08 |
Natural infection versus hybrid (natural and vaccination) humoral immune response to SARS-COV-2: A comparative paired analysis |
L. Abdelwareth, F. Alhousani, R. Abuyadek, J. Donnelly, A. Leinberger-Jabari, S. Atef, R.H. Al-Rifai |
86 |
[GO] |
2024―May―08 |
Pediatric multisystemic inflammatory syndrome associated to SARS-Cov2 |
I. Mezghani, M. Turki, A. Elleuch, F. Ayedi |
87 |
[GO] |
2024―May―08 |
Epidemiology of respiratory viruses (Excluding SARS-COV2) at the military hospital of instruction mohammed v (HMIMV) of rabat: Retrospective study over a period of 44 month (SEPTEMBER 2019 - APRIL 2023) |
R. Tagajdid |
88 |
[GO] |
2024―May―08 |
Frequency of carbapenem resistant providencia stuartii isolation from clinical samples in relation to colistin consumption in the ICU of a tertiary hospital before and during the pandemic (2019-2022) |
C. Zarras, K. Zarras, E. Christou, A. Pyrpasopoulou, C. Michailidou, K. Mpani, et al. (+3) M. Mpiska, P. Soukiouroglou, E. Vagdatli |
89 |
[GO] |
2024―May―08 |
Determination of direct oral anticoagulant in the emergency laboratory: The experience in pandemic and post-pandemic period |
C. Scarone, v. Dovere, c. Traverso, f. Lillo |
90 |
[GO] |
2024―May―08 |
Comparative analysis of global regulations for IVDs in the pandemic situation |
M.S. Noh |
91 |
[GO] |
2024―Jan―05 |
Evaluation of diagnostic performance of SARS-CoV-2 infection using digital droplet polymerase chain reaction in individuals with or without COVID-19 symptoms |
Yoonjung Kim, Eunyoung Lee, Boyeon Kim, Jinhee Cho, Sook-Won Ryu, Kyung-A Lee |
92 |
[GO] |
2024―Jan―04 |
Quality and composition of archived nucleic acids after use in SARS-CoV-2 molecular testing |
Ho Hyun Song, Jong Cheul Choi, Ran Lee, Sook Kyung Yoon, Hye Jeong Park, Young Hee Shin, et al. (+2) Jeong Won Shin, Jieun Kim |
93 |
[GO] |
2023―Nov―30 |
Longitudinal Impact of COVID-19 Pandemic on the Utilization of Hemoglobin A1c Testing in Outpatients |
Li Zha, Sara MacLeod, Tanzy Love, Robert J. Fortuna, Y. Victoria Zhang |
94 |
[GO] |
2023―Oct―21 |
Plasma SARS-CoV-2 N antigen is a powerful molecular marker for early detection of severe COVID-19 in patients and monitoring disease progression |
Xiaoyan Teng, Liuping Hu, Jiazhen Shen, Jiudong Hu, Xiaoyan Wu, Yuzhen Du |
95 |
[GO] |
2023―Oct―05 |
The possible role of quinolinic acid as a predictive marker in patients with SARS-CoV-2 |
Simon Michaelis, Sieglinde Zelzer, Christopher Schneider, Wolfgang J. Schnedl, Andreas Baranyi, Andreas Meinitzer, et al. (+2) Markus Herrmann, Dietmar Enko |
96 |
[GO] |
2023―Aug―05 |
Evaluation of iron metabolism in hospitalized COVID-19 patients |
Thibaud Lefebvre, Anne Boutten, Celia Raulet-Bussian, Alexandre Raynor, Hana Manceau, Hervé Puy, et al. (+9) Boualem Moulouel, Caroline Schmitt, Jean François Timsit, Agnès Lefort, Emmanuel Weiss, Francois Xavier Lescure, Jean-Damien Ricard, Romain Sonneville, Katell Peoc'h |
97 |
[GO] |
2023―Jun―03 |
CBPH assay for the highest sensitive detection of SARS-COV-2 in the semen |
Shuai-Feng Zhou, Chuan Huang, Shi-Kang Li, Xiao-Lei Long, Yu Chen, Zhi-Fei Zhan, et al. (+9) Shi-Xiong Hu, Chun-Sheng Hu, Lu Chen, Shi-Ping Wang, Li-Qing Fan, Wei-Jun Chen, Li-Dong Gao, Wen-Bing Zhu, Xue-Jun Ma |
98 |
[GO] |
2023―May―15 |
Immunology of SARS-CoV-2 infection and vaccination |
Baoxu Lin, Linlin Cheng, Jin Zhang, Mei Yang, Yixiao Zhang, Jianhua Liu, Xiaosong Qin |
99 |
[GO] |
2023―Mar―13 |
Letter to the editor regarding: “A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population”. Clinica Chimica Acta 538 (2023) 211-215 |
Janice L. Atkins, Mitchell Lucas, Luke C. Pilling, David Melzer |
100 |
[GO] |
2023―Mar―05 |
Designing and developing a sensitive and specific SARS-CoV-2 RBD IgG detection kit for identifying positive human samples |
Ehsan Raoufi, Fatemeh Hosseini, Bahman Onagh, Mohammad Salehi-Shadkami, Marjan Mehrali, Monireh Mohsenzadegan, et al. (+6) Jim Q. Ho, Banafsheh Bigdelou, Mohammad Reza Sepand, Thomas J. Webster, Steven Zanganeh, Mohammad M. Farajollahi |
101 |
[GO] |
2023―Jan―11 |
Time series analysis revealed prognostic value of continuous nasopharyngeal SARS-CoV-2 nucleic acid quantification for COVID-19: A retrospective study of >3,000 COVID-19 patients from 2 centers |
Zhiyuan Wu, Can Yang, Yutao Shen, Qingyun Zhang, Xuemei Tang, Di Wang, et al. (+14) Yu Xu, Guojun Cao, Xiaodong Song, Yanchun Ma, Huajie Fan, Hailong Lu, Yaju Li, Xiangyu Li, Yiqin Shen, Chen Zhang, Min Zhu, Xiaoyan Teng, Yuzhen Du, Ming Guan |
102 |
[GO] |
2022―Dec―24 |
A haemochromatosis-causing HFE mutation is associated with SARS-CoV-2 susceptibility in the Czech population |
J.A. H뫎k, T. Philipp, V. Adamkova, O. Majek, L. Dusek |
103 |
[GO] |
2022―Dec―15 |
Evaluation of reverse transcriptase-polymerase spiral reaction assay for rapid and sensitive detection of severe acute respiratory syndrome coronavirus 2 |
Sharan Prerana, Pai Ashwini, Karanth Padyana Anupama, Valakkunja Shankaranarayana Prajna, Kattapuni Suresh Prithvisagar, Ashwath Nayak, et al. (+5) Praveen Rai, Anusha Rohit, Indrani Karunasagar, Iddya Karunasagar, Biswajit Maiti |
104 |
[GO] |
2022―Nov―18 |
COVID-19 Diagnostics: Molecular biology to Nanomaterials |
Summaya Perveen, Anjali Negi, Varun Gopalakrishnan, Satyajit Panda, Vinay Sharma, Rashmi Sharma |
105 |
[GO] |
2022―Oct―29 |
Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection |
Lucia Salvioni, Filippo Testa, Adela Sulejmani, Francesca Pepe, Pietro Giorgio Lovaglio, Paolo Berta, et al. (+6) Roberto Dominici, Valerio Leoni, Davide Prosperi, Giorgio Vittadini, Miriam Colombo, Luisa Fiandra |
106 |
[GO] |
2022―Oct―21 |
Alteration of the kynurenine pathway is inversely associated with the humoral immune response in patients with SARS-CoV-2 |
Simon Michaelis, Sieglinde Zelzer, Christopher Schneider, Wolfgang J. Schnedl, Andreas Baranyi, Andreas Meinitzer, et al. (+2) Markus Herrmann, Dietmar Enko |
107 |
[GO] |
2022―Oct―10 |
Salivary proteomic analysis in asymptomatic and symptomatic SARS-CoV-2 infection: innate immunity, taste perception and FABP5 proteins make the difference |
Ada Aita, Ilaria Battisti, Nicole Contran, Serena Furlan, Andrea Padoan, Cinzia Franchin, et al. (+6) Francesco Barbaro, Anna Maria Cattelan, Carlo-Federico Zambon, Mario Plebani, Daniela Basso, Giorgio Arrigoni |
108 |
[GO] |
2022―Sep―17 |
Angiotensin-converting enzyme 1 and voltage-gated potassium channel-interacting protein 4 gene polymorphisms in COVID-19 patients from East of Iran |
Hamid Abbaszadeh, Fariba Mohammadi, Mahdieh Rajabi-Moghaddam, Hamid Kabiri-Rad, Shokouh Ghafari, Farshid Abedi, Ebrahim Miri-Moghaddam |
109 |
[GO] |
2022―Sep―17 |
Miniaturized Real-Time PCR systems for SARS-CoV-2 detection at the Point-of-Care |
Valeria Garzarelli, Maria Serena Chiriacò, Marco Cereda, Isidora Autuori, Francesco Ferrara |
110 |
[GO] |
2022―Sep―14 |
Development of multiplex S-gene-targeted RT-PCR for rapid identification of SARS-CoV-2 variants by extended S-gene target failure |
Yuri Imaizumi, Takayuki Ishige, Tatsuki Fujikawa, Akiko Miyabe, Shota Murata, Kenji Kawasaki, et al. (+4) Motoi Nishimura, Toshibumi Taniguchi, Hidetoshi Igari, Kazuyuki Matsushita |
111 |
[GO] |
2022―Aug―18 |
Covid-19 and adolescent acute kidney injury: Renal recovery with combined enalapril and estrogen therapy |
E Scott Sills, Samuel H Wood, Anthony P H Walsh |
112 |
[GO] |
2022―Jun―14 |
Elucidation of Correlation Between SARS-CoV-2 RdRp and N Gene Cycle Threshold (Ct) by RT-PCR with Age and Gender |
Mati Ur Rehman, Syed Sajjad Naqvi, Rooh Ullah, Narmeen Arshad, Muhammad Ammad, Qurat Ul Ain, et al. (+4) Anam Razzak, Muhammad Yousaf, Arif Hussain, Tarique N. Hasan |
113 |
[GO] |
2022―Jun―10 |
M193 Clinical performance of the standard F COVID-19 AG FIA for the detection of SARS-COV-2 infection |
S. Jirungda, P. Khamphrom, K. Klaprajun, T. Prachakul, J. Kraisin |
114 |
[GO] |
2022―Jun―10 |
T125 impact of the Covid-19 crisis on the point-of-care blood gases management in an ISO 22870 accredited laboratory in Paris (France) |
M. Vaubourdolle, B. Beneteau-Burnat, C. Aussel, P. Pernet |
115 |
[GO] |
2022―Jun―10 |
M125 Simulation models to predict biochemistry test capacity in Covid-19 pandemic surge capacity planning in tertiary care centres |
B. Kyle, A. Bajkov, D. Haugrud, F. Wu, A. Lyon, M. Lyon |
116 |
[GO] |
2022―Jun―10 |
W097 Usefulness of urine biomarkers for the prediction of in-hospital mortality in the COVID-19 patients |
D. Morell-Garcia, D. Ramos-Chavarino, J.M. Bauça, P. Argente Del Castillo, M.A. Ballesteros-Vizoso, B. García, et al. (+5) L. Valiña, C. Gómez-Cobo, L. García De Guadiana Romualdo, I. Llompart, A.M. García-Raja |
117 |
[GO] |
2022―Jun―10 |
W182 Association between nutritional and inflammatory biomarkers in COVID-19 patients with chronic kidney disease |
V. Khurana, B. Goswami, S. Kaushik |
118 |
[GO] |
2022―Jun―10 |
T259 Evaluation of coagulation function in critically ill patients with severe Covid-19 pneumonia |
I. RodrÍguez MartÍn, J. Montenegro Martinez, D. Nuñez Jurado |
119 |
[GO] |
2022―Jun―10 |
T256 Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe Covid-19 Pneumonia |
I. RodrÍguez MartÍn, J. Montenegro Martinez, M. Santana Morales, J.M. Guerrero Montávez |
120 |
[GO] |
2022―Jun―10 |
T222 Screening for Covid-19 with cellular morphometric parameters on the routine hematology analyzer DXH 800 |
M. Vasse, M. Ballester, D. Ayaka, D. Sukhachev, F. Delcominette, E. Sukhacheva, et al. (+4) F. Habarou, E. Jolly, T. Pascreau, E. Farfour |
121 |
[GO] |
2022―Jun―10 |
W137 Comparison of two RT PCR methods with two different genes for detection of severe acute respiratory syndrome coronavirus 2 (SARS-COV2) |
M. Alabdullatif, A. Hazizi, A. Alsadoon, F. Albloui, Y. Hawsawi, F. Alseraye, W. Tamimi |
122 |
[GO] |
2022―Jun―10 |
W124 Comparison of two RT PCR methods with two different genes for detection of severe acute respiratory syndrome coronavirus 2 (SARS-COV2) |
M. Alabdullatif, A. Hazizi, A. Alsadoon, F. Albloui, Y. Hawsawi, F. Alseraye, W. Tamimi |
123 |
[GO] |
2022―Jun―10 |
W102 Correlation between the atellica SARS-COV-2 IGG assay results and the presence of SARS-COV-2 neutralizing antibodies |
J. Bedini, X. Filella, S. Hidalgo, C. Gonzalez-Escribano |
124 |
[GO] |
2022―Jun―10 |
T102 Has the SARS-COV-2 pandemic affected cardiovascular risk parameters in the general population? |
M. Chlabicz, J. Jamiołkowski, A. Szum-Jakubowska, P. Sowa, M. Dubatówka, M. Łapińska, et al. (+7) M. Kondraciuk, J. Motyka, M. Chlabicz, A. Szpakowicz, S. Ławicki, A. Moniuszko-Malinowska, K. Kamiński |
125 |
[GO] |
2022―Jun―10 |
W101 Stable preservation of SARS-COV-2 RNA from gargle samples on FTA cards |
G. Kriegshäuser, A. Berndt, D. Alpar, C. Oberkanins |
126 |
[GO] |
2022―Jun―10 |
M278 Serological antibody response to SARS-COV-2 vaccination in a large cohort of Canadian children, adolescents, and adults |
M.K. Bohn, S. Wilson, K. Adeli |
127 |
[GO] |
2022―Jun―10 |
M090 Interleukine 6 is associated with severity and poor outcome in ICU-patients with SARS-CoV-2 infection |
N. Mario, J. Lavillegrand, M. Garnier, A. Spaeth, T. Urbina, Y. Chantran, et al. (+4) M. Fartoukh, B. Guidet, H. Ait-Oufella, M. Vaubourdolle |
128 |
[GO] |
2022―Jun―08 |
T-cell proliferation assay for the detection of SARS-CoV-2-specific T-cells |
Chang Chu, Anne Schönbrunn, Saban Elitok, Florian Kern, Karsten Schnatbaum, Holger Wenschuh, et al. (+4) Kristin Klemm, Volker von Baehr, Bernhard K. Krämer, Berthold Hocher |
129 |
[GO] |
2022―Jun―06 |
A 14+7 day quarantine period and a dual nucleic acid testing reagent strategy detect potentially indiscoverable Coronavirus disease 2019 infections in Xiamen, China |
Yong-Jing Wang, Jian-Hang Xue, Zan-Xi Fang, Jia-Wen Xie, Jian-Jun Niu, Tian-Ci Yang, Li-Rong Lin |
130 |
[GO] |
2022―Jun―02 |
At-admission HbA1c levels in Hospitalized COVID-19 Participants With and Without Known Diabetes |
Andrea Valle, Javier Rodriguez, Félix Camiña, Miguel A Martínez-Olmos, Juan B Ortola, Santiago Rodriguez-Segade |
131 |
[GO] |
2022―May―10 |
SARS-CoV-2 RNA Detection in Formalin-Fixed Paraffin-Embedded (FFPE) Tissue by Droplet Digital PCR (ddPCR) |
Ramanath Majumdar, Julie A. Vrana, Justin W. Koepplin, Dragana Milosevic, Anja C. Roden, Joaquin J. Garcia, et al. (+2) Benjamin R. Kipp, Ann M. Moyer |
132 |
[GO] |
2022―Apr―29 |
Semi-nested RT-PCR enables sensitive and high-throughput detection of SARS-CoV-2 based on melting analysis |
Anh Thi Ngoc Nguyen, Hoai Thi Bui, Quynh Thi-Huong Pham, Ly Thi Thao Hoang, Hung Xuan Ta, Timo Heikkinen, et al. (+25) Duyet Van Le, Trang Dinh Van, Nam Quoc Ngo, Phuong Thi Hong Huynh, Trang Thi Huyen Tran, Hoan Quoc Phan, Luong Van Hoang, H.Rogier van Doorn, Diep Thi Ngoc Nguyen, Tam Thi Nguyen, Nam Sy Vo, Cuong Viet Vo, Sau Khac Trinh, Tai The Pham, Quang Duc Le, Phan Van Le, Son Thai Nguyen, Loan Thi Tran, Toan Dinh Vu, Quynh Anh Nguyen Vu, Nguyet Thi Trieu, Thuy Thi Le, Ung Dinh Nguyen, Jakob Steman, Tho Huu Ho |
133 |
[GO] |
2022―Apr―09 |
Molecular Diagnostics of SARS-CoV-2: Findings of an International Survey |
Aldo Vacaflores Salinas, Tester Ashavaid, Deborah A. Payne, Mark W. Linder, Katarina Baluchova, Shiyang Pan, et al. (+2) Jim Huggett, Parviz Ahmad-Nejad |
134 |
[GO] |
2022―Mar―16 |
Tracking SARS-CoV-2 variants by entire S-gene analysis using long-range RT-PCR and Sanger sequencing |
Mirai Matsubara, Yuri Imaizumi, Tatsuki Fujikawa, Takayuki Ishige, Motoi Nishimura, Akiko Miyabe, et al. (+5) Shota Murata, Kenji Kawasaki, Toshibumi Taniguchi, Hidetoshi Igari, Kazuyuki Matsushita |
135 |
[GO] |
2022―Mar―10 |
Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients |
An Bracke, Emilie De Hert, Michelle De bruyn, Karen Claesen, Gwendolyn Vliegen, Alexandra Vujkovic, et al. (+13) Lida van Petersen, Fien HR De Winter, An Hotterbeekx, Isabel Brosius, Caroline Theunissen, Sabrina Van Ierssel, Maartje van Frankenhuijsen, Erika Vlieghe, Koen Vercauteren, Pieter Van der Veken, Dirk Hendriks, Samir Kumar-Singh, Ingrid De Meester |
136 |
[GO] |
2022―Feb―21 |
Two rapid SARS-CoV-2 disposable devices for semi-quantitative S-RBD antibody levels determination compared with CLIA and ELISA assays at different protective thresholds |
Andrea Padoan, Chiara Cosma, Luisa Galla, Daniela Basso, Mario Plebani |
137 |
[GO] |
2022―Jan―05 |
The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients |
Ola Hammarsten, Pontus Ljungqvist, Björn Redfors, Mathias Wernbom, Hannes Widing, Bertil Lindahl, et al. (+6) Sabin Salahuddin, Ruwyada Sammantar, Sandeep Jha, Annica Ravn-Fisher, Magnus Brink, Magnus Gisslen |
138 |
[GO] |
2021―Dec―25 |
Answer to the letter of Lippi & Plebani entitled “Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal” |
Giacomo Malipiero, Danilo Villalta |
139 |
[GO] |
2021―Dec―24 |
Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal |
Giuseppe Lippi, Mario Plebani |
140 |
[GO] |
2021―Dec―14 |
Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types |
Louis Nevejan, Thomas Strypens, Mathias Van Nieuwenhove, An Boel, Lien Cattoir, Peter Meeus, et al. (+3) Xavier Bossuyt, Nikolaas De Neve, Lieve Van Hoovels |
141 |
[GO] |
2021―Dec―10 |
Performance Verification of Five Commercial RT-qPCR Diagnostic Kits for SARS-CoV-2 |
Mei Yang, Shuang Cao, Yong Liu, Zhijie Zhang, Rui Zheng, Yuzhong Li, et al. (+4) Jie Zhou, Chengguo Zong, Desheng Cao, Xiaosong Qin |
142 |
[GO] |
2021―Dec―10 |
Assessment of tryptophan and kynurenine as prognostic markers in patients with SARS-CoV-2 |
Simon Michaelis, Sieglinde Zelzer, Wolfgang J. Schnedl, Andreas Baranyi, Andreas Meinitzer, Dietmar Enko |
143 |
[GO] |
2021―Nov―27 |
Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2 |
Giacomo Malipiero, Pierlanfranco D'Agaro, Ludovica Segat, Anna Moratto, Danilo Villalta |
144 |
[GO] |
2021―Nov―12 |
Serum level of testosterone predicts disease severity of male COVID-19 patients and is related to T-cell immune modulation by transcriptome analysis |
Shufa Zheng, Qianda Zou, Dan Zhang, Fei Yu, Jiaqi Bao, Bin Lou, et al. (+9) Guoliang Xie, Sha Lin, Ruonan Wang, Weizhen Chen, Qi Wang, Yun Teng, Baihuan Feng, Yifei Shen, Yu Chen |
145 |
[GO] |
2021―Oct―29 |
SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): kinetics and comparison with chemiluminescent assays |
Andrea Padoan, Chiara Cosma, Francesco Bonfante, Foscarina della Rocca, Francesco Barbaro, Claudia Santarossa, et al. (+7) Luigi Dall'Olmo, Matteo Pagliari, Alessio Bortolami, Annamaria Cattelan, Vito Cianci, Daniela Basso, Mario Plebani |
146 |
[GO] |
2021―Oct―29 |
IgG antibodies against SARS-CoV-2 decay but persist 4 months after vaccination in a cohort of healthcare workers |
Giulia Brisotto, Elena Muraro, Marcella Montico, Chiara Corso, Chiara Evangelista, Mariateresa Casarotto, et al. (+7) Cristina Caffau, Roberto Vettori, Maria Rita Cozzi, Stefania Zanussi, Matteo Turetta, Federico Ronchese, Agostino Steffan |
147 |
[GO] |
2021―Sep―29 |
Antibody response induced by the boost overdose during COVID-19 heterologous prime-boost vaccination strategy |
Francisco Raposo, Giuseppe Lippi |
148 |
[GO] |
2021―Sep―21 |
Endothelial dysfunction and Mid-Regional proAdrenomedullin: what role in SARS-CoV-2 infected Patients? |
Martina Zaninotto, Monica Maria Mion, Lucio Marchioro, Andrea Padoan, Mario Plebani |
149 |
[GO] |
2021―Aug―20 |
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects |
Davide Ferrari, Nicola Clementi, Sestina Maria Spanò, Sami Albitar-Nehme, Stefania Ranno, Alessandra Colombini, et al. (+10) Elena Criscuolo, Chiara Di Resta, Rossella Tomaiuolo, Marco Viganó, Nicasio Mancini, Elena De Vecchi, Massimo Locatelli, Alessandra Mangia, Carlo Federico Perno, Giuseppe Banfi |
150 |
[GO] |
2021―Aug―16 |
Sources and clinical significance of aspartate aminotransferase increases in COVID-19 |
Elena Aloisio, Giulia Colombo, Claudia Arrigo, Alberto Dolci, Mauro Panteghini |
151 |
[GO] |
2021―Aug―05 |
Previous vitamin D status and total cholesterol are associated with SARS-CoV-2 infection |
Heriks Gomes Ribeiro, Raquel Costa Silva Dantas-Komatsu, Jeane Franco Pires Medeiros, Maria Clara da Cruz Carvalho, Victor de Lima Soares, Bruna Zavarize Reis, et al. (+2) André Ducati Luchessi, Vivian Nogueira Silbiger |
152 |
[GO] |
2021―Jul―16 |
A theoretical simulation of SARS-CoV-2 pooled testing: pooled sample collection outperforms pooled RNA extraction |
Yugan He, Yigang Tong |
153 |
[GO] |
2021―Jun―16 |
Comparison of Two Digital PCR Methods for EGFR DNA and SARS-CoV-2 RNA Quantification |
Sang-Soo Lee, Jae-Hyeong Park, Young-Kyung Bae |
154 |
[GO] |
2021―May―21 |
Combination of lymphocyte count and not the serological response with high-sensitivity cardiac troponin for risk stratification in patients with possible COVID-19 |
Saranya Kittanakom, Peter A Kavsak |
155 |
[GO] |
2021―May―03 |
ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors |
Jaroslav A. H뫎k, Ladislav Dusek, Ondrej Majek, Vaclav Adamek, Tereza Cervinkova, Dana Dlouha, Vera Adamkova |
156 |
[GO] |
2021―Apr―30 |
Clinical laboratory evaluation of COVID-19 |
Chen Zhufeng, Xu Wanju, Ma Wanshan, Shi Xiaohong, Li Shuomin, Hao Mingju, et al. (+2) Fang Yuanxun, Zhang Li |
157 |
[GO] |
2021―Apr―28 |
The Effect of the Covid-19 Shutdown on Glycemic Testing and Control |
Anu Sharma, Dina N. Greene, Allison B. Chambliss, Christopher W. Farnsworth, Deborah French, Daniel S. Herman, et al. (+9) Peter A. Kavsak, Anna E. Merrill, Sheng-Ying Margaret Lo, Martha E. Lyon, Gabrielle Winston-McPherson, Lauren N. Pearson, Jeffrey A. SoRelle, Avantika C. Waring, Robert L. Schmidt |
158 |
[GO] |
2021―Apr―27 |
Evaluation of 32 rapid tests for detection of antibodies against SARS-CoV-2 |
Mette C. Tollånes, Pål A. Jenum, Helene Kierkegaard, Eirik Abildsnes, Roar Magne Bævre-Jensen, Anne C. Breivik, Sverre Sandberg |
159 |
[GO] |
2021―Apr―24 |
Comparative analysis of chemical breath-prints through olfactory technology for the discrimination between SARS-CoV-2 infected patients and controls |
Maribel Rodríguez-Aguilar, Lorena Díaz de León-Martínez, Blanca Nohemí Zamora-Mendoza, Andreu Comas-García, Sandra Elizabeth Guerra Palomares, Christian Alberto García-Sepúlveda, et al. (+3) Luz Eugenia Alcántara-Quintana, Fernando Díaz-Barriga, Rogelio Flores-Ramírez |
160 |
[GO] |
2021―Apr―17 |
Methods Matter - Tailoring SARS-CoV-2 Antibody Targets to Vaccination Status |
Alexandra R. Rapp, John O. Ogunbileje, Diane Djouodo-Nemzou, Anthony O. Okorodudu |
161 |
[GO] |
2021―Apr―05 |
Clinical relevance of serum α-L-fucosidase activity in the SARS-CoV-2 infection |
En-yu Liang, Guo-hua Li, Wen-gong Wang, Xin-min Qiu, Pei-feng Ke, Min He, Xian-zhang Huang |
162 |
[GO] |
2021―Mar―17 |
Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: a method comparison of two different commercially available serological assays from the same manufacturer |
Thomas Mueller |
163 |
[GO] |
2021―Feb―24 |
Lipid metabolism changes in patients with severe COVID-19 |
Yi Li, Yan Zhang, Rongli Lu, Minhui Dai, Minxue Shen, Jianchu Zhang, et al. (+12) Yanhui Cui, Ben Liu, Fengyu Lin, Lingli Chen, Duoduo Han, Yifei Fan, Yanjun Zeng, Wen Li, Sha Li, Xiang Chen, Haitao Li, Pinhua Pan |
164 |
[GO] |
2021―Feb―22 |
Correlation of Krebs von den Lungen-6 and Fibronectin with pulmonary fibrosis in Coronavirus Disease 2019 |
Ding-Hui Peng, Yi Luo, Li-Jun Huang, Fan-Lu Liao, Yan-Yuan Liu, Peng Tang, et al. (+2) Han-Ning Hu, Wei Chen |
165 |
[GO] |
2021―Feb―21 |
Salivary SARS-CoV-2 antigen rapid detection: a prospective cohort study |
Daniela Basso, Ada Aita, Andrea Padoan, Chiara Cosma, Filippo Navaglia, Stefania Moz, et al. (+4) Nicole Contran, Carlo-Federico Zambon, Anna Maria Cattelan, Mario Plebani |
166 |
[GO] |
2021―Jan―22 |
rRT-PCR for SARS-CoV-2: analytical considerations |
Rezgar Rahbari, Nariman Moradi, Mohammad Abdi |
167 |
[GO] |
2020―Dec―13 |
Novel automated sample-to-result SARS-CoV-2 laboratory-developed RT-PCR assay for high-throughput testing using LabTurbo AIO 48 system |
Ming-Jr Jian, Hsing-Yi Chung, Chih-Kai Chang, Jung-Chung Lin, Kuo-Ming Yeh, Sheng-Kang Chiu, et al. (+7) Yi-Hui Wang, Shu-Jung Liao, Shih-Yi Li, Shan-Shan Hsieh, Cherng-Lih Perng, Feng-Yee Chang, Hung-Sheng Shang |
168 |
[GO] |
2020―Dec―04 |
The impact of biosafety enhancement on stat laboratory quality metrics: lessons from the COVID-19 pandemic |
John L. Frater, Jeanne Anderson |
169 |
[GO] |
2020―Dec―04 |
A Nomogram to Early Predict Isolation Length for Non-severe COVID-19 Patients Based on Laboratory Investigation: A Multicenter Retrospective Study in Zhejiang Province, China |
Yan Xia, Yan Zhang, Shijin Yuan, Jiangnan Chen, Wei Zheng, Xiaoping Xu, et al. (+2) Xinyou Xie, Jun Zhang |
170 |
[GO] |
2020―Nov―22 |
Serum potassium concentrations in COVID-19 |
Dominika Szoke, Simone Caruso, Elena Aloisio, Sara Pasqualetti, Alberto Dolci, Mauro Panteghini |
171 |
[GO] |
2020―Nov―05 |
Biclonal gammopathay in a case of severe COVID-19 |
Pooja Vashistha, Ajay Gupta, Mona Arya, Vijay Kumar Singh, Abhishek Dubey, Bidhan Chandra Koner |
172 |
[GO] |
2020―Nov―05 |
Differences of SARS-CoV-2 serological test performance between hospitalized and outpatient COVID-19 cases |
Johannes Wolf, Thorsten Kaiser, Sarah Pehnke, Olaf Nickel, Christoph Lübbert, Sven Kalbitz, et al. (+7) Benjamin Arnold, Jörg Ermisch, Luisa Berger, Stefanie Schroth, Berend Isermann, Stephan Borte, Ronald Biemann |
173 |
[GO] |
2020―Nov―05 |
Digital PCR is a sensitive new technique for SARS-CoV-2 detection in clinical applications |
Yanfang Jiang, Haifeng Wang, Sijia Hao, Yukun Chen, Jiaxue He, Yong Liu, et al. (+3) Liguo Chen, Yuanhua Yu, Shucheng Hua |
174 |
[GO] |
2020―Oct―21 |
The N gene of SARS-CoV-2 was the main positive component in repositive samples from a cohort of COVID-19 patients in Wuhan, China |
Xuzhao Zhang, Min Li, Bin Zhang, Tao Chen, Dong Lv, Pengfei Xia, et al. (+5) Zhuanyi Sun, Xiaoyan Shentu, Haiyan Chen, Libin Li, Wenbin Qian |
175 |
[GO] |
2020―Oct―15 |
Hock-a-loogie saliva as a diagnostic specimen for SARS-CoV-2 by a PCR-based assay: a diagnostic validity study |
Jian Fan, Fei Yu, Xiang Wang, Qianda Zou, Bin Lou, Guoliang Xie, et al. (+15) Xianzhi Yang, Weizhen Chen, Qi Wang, Dan Zhang, Ruonan Wang, Baihuan Feng, Yuejiao Dong, Li Huang, Yun Teng, Zhenzhen Deng, Ling Yu, Kaijin Xu, Jifang Sheng, Shufa Zheng, Yu Chen |
176 |
[GO] |
2020―Oct―12 |
Positive control synthesis method for COVID-19 diagnosis by one-step real-time RT-PCR |
Hyejin Cho, Young Hwan Jung, Hong Bum Cho, Hee-tae Kim, Kwang-sun Kim |
177 |
[GO] |
2020―Oct―12 |
Evaluation of the clinical performance of single-, dual-, and triple-target SARS-CoV-2 RT-qPCR methods |
Xiaomei Hu, Lingxiang Zhu, Yijun Luo, Qinfei Zhao, Chianru Tan, Xiao Chen, et al. (+13) Huijuan Zhang, Xiaojun Hu, Linping Lu, Yongwei Xiao, Shao Huang, Yingke He, Jacqueline Sim Xiu Ling, Shisheng Su, Fang Wang, Yanke Peng, Jigang Wang, Yong Guo, Tianyu Zhong |
178 |
[GO] |
2020―Oct―01 |
Cardiac troponin I in SARS-CoV-2-patients: the additional prognostic value of serial monitoring |
Martina Zaninotto, Monica Maria Mion, Andrea Padoan, Luciano Babuin, Mario Plebani |
179 |
[GO] |
2020―Sep―29 |
SARS-CoV-2 infection serology validation of different methods: usefulness of IgA in the early phase of infection |
Massimo Pieri, Marco Ciotti, Nicoletta Carlozzi, Maria Loredana Frassanito, Arianna Meloni, Alessandro Cistera, et al. (+5) Giordano Turchetti, Silvia Niscola, Giuseppe Labate, Graziella Calugi, Sergio Bernardini |
180 |
[GO] |
2020―Sep―19 |
Clinical Performance of A Semi-Quantitative Assay for SARS-CoV2 IgG and SARS-CoV2 IgM Antibodies |
Joanna Jung, Emily Garnett, Purviben Jariwala, Hue Pham, Rongrong Huang, Eduardo Benzi, et al. (+4) Niveen Issaq, Martin Matzuk, Ila Singh, Sridevi Devaraj |
181 |
[GO] |
2020―Sep―16 |
SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis |
Ada Aita, Daniela Basso, Anna Maria Cattelan, Paola Fioretto, Filippo Navaglia, Francesco Barbaro, et al. (+6) Alice Stoppa, Enrico Coccorullo, Assunta Farella, Aurora Socal, Roberto Vettor, Mario Plebani |
182 |
[GO] |
2020―Sep―15 |
Update on Serologic Testing in COVID-19 |
Rafał Krajewski, Justyna Gołębiowska, Sebastian Makuch, Grzegorz Mazur, Siddarth Agrawal |
183 |
[GO] |
2020―Sep―08 |
Saliva for use with a point of care assay for the rapid diagnosis of COVID-19 |
Jeffrey A. SoRelle, Lenin Mahimainathan, Clare McCormick-Baw, Dominick Cavuoti, Francesca Lee, Abey Thomas, et al. (+3) Ravi Sarode, Andrew E. Clark, Alagarraju Muthukumar |
184 |
[GO] |
2020―Sep―08 |
Performance of an automated chemiluminescence SARS-COV-2 IG-G Assay |
C.S. Lau, H.M.L. Oh, S.P. Hoo, Y.L. Liang, S.K. Phua, T.C. Aw |
185 |
[GO] |
2020―Aug―25 |
Comparison of qualitative and quantitative analyses of COVID-19 clinical samples |
Yan Dang, Ning Liu, Chianru Tan, Yingmei Feng, Xingxing Yuan, Dongdong Fan, et al. (+4) Yanke Peng, Ronghua Jin, Yong Guo, Jinli Lou |
186 |
[GO] |
2020―Aug―18 |
Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity |
Andrea Padoan, Francesco Bonfante, Silvia Zuin, Chiara Cosma, Daniela Basso, Mario Plebani |
187 |
[GO] |
2020―Aug―14 |
Laboratory Findings in COVID-19 Diagnosis and Prognosis |
Atieh Pourbagheri-Sigaroodi, Davood Bashash, Fatemeh Fateh, Hassan Abolghasemi |
188 |
[GO] |
2020―Aug―12 |
Potential diagnostics and therapeutic approaches in COVID-19 |
Pratibha Kumari, Archana Singh, Moses Rinchui Ngasainao, Ilma Shakeel, Sanjay Kumar, Seema Lal, et al. (+4) Anchal Singhal, Sukhwinder Singh Sohal, Indrakant Kumar Singh, Md. Imtaiyaz Hassan |
189 |
[GO] |
2020―Aug―10 |
ACE deletion allele is associated with susceptibility to SARS-CoV-2 infection and mortality rate: An epidemiological study in the Asian population |
Abhijit Pati, Harishankar Mahto, Sunali Padhi, Aditya K Panda |
190 |
[GO] |
2020―Aug―07 |
Ethical and organizational considerations for mandatory COVID-19 vaccination of health care workers: a clinical laboratorian's perspective |
Raffick A.R. Bowen |
191 |
[GO] |
2020―Jul―24 |
COVID-19 infection and Thrombosis |
Swati Srivastava, Iti Garg, Anju Bansal, Bhuvnesh Kumar |
192 |
[GO] |
2020―Jul―16 |
The diagnostic and prognostic role of myocardial injury biomarkers in hospitalized patients with COVID-19 |
Pingji Deng, Zunqiong Ke, Binwu Ying, Bin Qiao, Leyong Yuan |
193 |
[GO] |
2020―Jul―16 |
SARS-CoV-2 and the cardiovascular system |
Anouar Hafiane |
194 |
[GO] |
2020―Jul―14 |
Insights into pediatric multi-system inflammatory syndrome and COVID-19 |
David Bar-Or, Leonard T. Rael, Edward N. Brody |
195 |
[GO] |
2020―Jul―11 |
COVID-19: review and hematologic impact |
Sílvia Letícia de Oliveira Toledo, Leilismara Sousa Nogueira, Maria das Graças Carvalho, Danyelle Romana Alves Rios, Melina de Barros Pinheiro |
196 |
[GO] |
2020―Jul―10 |
Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection |
Xingzhong Hu, Dong Chen, Lianpeng Wu, Guiqing He, Wei Ye |
197 |
[GO] |
2020―Jul―10 |
CCR5 Δ32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: An epidemiological investigation |
Aditya K. Panda, Archana Padhi, B. Anjan Kumar Prusty |
198 |
[GO] |
2020―Jul―07 |
Time-dependent changes in the clinical characteristics and prognosis of hospitalized COVID-19 patients in Wuhan, China: A retrospective study |
Menglong Wang, Jishou Zhang, Di Ye, Zhen Wang, Jianfang Liu, Hua He, et al. (+12) Bo Shen, Zhen Luo, Jing Ye, Yao Xu, Mengmeng Zhao, Mingxiao Liu, Pingan Zhang, Jian Gu, Wei Pan, Menglin Liu, Dan Li, Jun Wan |
199 |
[GO] |
2020―Jul―07 |
Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU |
Dong Zhang, Xiang Zhou, Songxin Yan, Ran Tian, Longxiang Su, Xin Ding, et al. (+11) Meng Xiao, Yu Chen, Hua Zhao, Huan Chen, Hongmin Zhang, Zunzhu Li, Qi Li, Yingchun Xu, Xiaowei Yan, Yongzhe Li, Shuyang Zhang |
200 |
[GO] |
2020―Jul―02 |
Laboratory Diagnosis of Coronavirus Disease-2019 (COVID-19) |
Chenxi Li, Chengxue Zhao, Jingfeng Bao, Bo Tang, Yunfeng Wang, Bing Gu |
201 |
[GO] |
2020―Jun―27 |
Less expression of CD4+ and CD8+ T cells might reflect the severity of infection and predict worse prognosis in patients with COVID-19: evidence from a pooled analysis |
Daojun Hu, Li Li, Wenjie Shi, Li Zhang |
202 |
[GO] |
2020―Jun―21 |
Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator? |
Jenifer Gómez-Pastora, Mitchell Weigand, James Kim, Xian Wu, Jacob Strayer, Andre F. Palmer, et al. (+3) Maciej Zborowski, Mark Yazer, Jeffrey J. Chalmers |
203 |
[GO] |
2020―Jun―20 |
Impact of Heat-Inactivation on the detection of SARS-CoV-2 IgM and IgG Antibody by ELISA |
Xiumei Hu, Ruyi Zhang, Taixue An, Qiang Li, Bo Situ, Zihao Ou, et al. (+7) Changmeng Wu, Biao Yang, Peifu Tian, Yuhai Hu, Baohong Ping, Qian Wang, Lei Zheng |
204 |
[GO] |
2020―Jun―17 |
Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19 |
Yuqin Wu, Zhicai Feng, Peng Li, Qizhi Yu |
205 |
[GO] |
2020―Jun―16 |
Cautious interpretation of antiphospholipid antibodies in COVID-19 |
Sudhir Mehta, Sudhir Bhandari, Shaurya Mehta |
206 |
[GO] |
2020―Jun―11 |
Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis |
Takayuki Yamada, Mako Wakabayashi, Takahiro Yamaji, Nitin Chopra, Takahisa Mikami, Hirotaka Miyashita, Satoshi Miyashita |
207 |
[GO] |
2020―Jun―10 |
Cytokine Storm Induced by SARS-CoV-2 |
Peipei Song, Wei Li, Jianqin Xie, Yanlong Hou, Chongge You |
208 |
[GO] |
2020―Jun―09 |
Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients |
Poggiali Erika, Zaino Domenica, Immovilli Paolo, Rovero Luca, Losi Giulia, Dacrema Alessandro, et al. (+7) Nuccetelli Marzia, Vadacca Giovanni Battista, Guidetti Donata, Vercelli Andrea, Magnacavallo Andrea, Bernardini Sergio, Terracciano Chiara |
209 |
[GO] |
2020―Jun―08 |
Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma |
Christian Bundschuh, Margot Egger, Kurt Wiesinger, Christian Gabriel, Martin Clodi, Thomas Mueller, Benjamin Dieplinger |
210 |
[GO] |
2020―Jun―06 |
Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19 |
Jingfeng Bao, Chenxi Li, Kai Zhang, Haiquan Kang, Wensen Chen, Bing Gu |
211 |
[GO] |
2020―Jun―05 |
C-reactive protein: a promising biomarker for poor prognosis in COVID-19 infection |
Bikash R Sahu, Raj Kishor Kampa, Archana Padhi, Aditya K. Panda |
212 |
[GO] |
2020―Jun―04 |
SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays |
He Sarina Yang, Sabrina E. Racine-Brzostek, William T. Lee, Danielle Hunt, Jim Yee, Zhengming Chen, et al. (+11) Jeffrey Kubiak, Miguel Cantu, Layla Hatem, Elaine Zhong, Danielle D'Ambrosio, Amy Chadburn, Lars Westblade, Marshall Glesby, Massimo Loda, Melissa M. Cushing, Zhen Zhao |
213 |
[GO] |
2020―Jun―03 |
Elevated monocyte distribution width in COVID-19 patients: The contribution of the novel sepsis indicator |
Agostino Ognibene, Maria Lorubbio, Pasqualino Magliocca, Emanuela Tripodo, Guendalina Vaggelli, Giovanni Iannelli, et al. (+6) Marco Feri, Raffaele Scala, Alessandro Polcini Tartaglia, Angelo Galano, Alessandro Pancrazzi, Danilo Tacconi |
214 |
[GO] |
2020―May―30 |
Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDITM enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma |
Margot Egger, Christian Bundschuh, Kurt Wiesinger, Christian Gabriel, Martin Clodi, Thomas Mueller, Benjamin Dieplinger |
215 |
[GO] |
2020―May―30 |
Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays? |
Mario Plebani, Andrea Padoan, Davide Negrini, Benedetta Carpinteri, Laura Sciacovelli |
216 |
[GO] |
2020―May―29 |
COVID-19: Transmission, prevention, and potential therapeutic opportunities |
Melika Lotfi, Michael R. Hamblin, Nima Rezaei |
217 |
[GO] |
2020―May―23 |
An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19 |
Mostafa Saadat |
218 |
[GO] |
2020―May―14 |
The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: a sentinel? |
Da-wei Sun, Dong Zhang, Run-hui Tian, Yang Li, Yu-shi Wang, Jie Cao, et al. (+9) Ying Tang, Nan Zhang, Tao Zan, Lan Gao, Yan-zhu Huang, Chang-lei Cui, Dong-xuan Wang, Yang Zheng, Guo-yue Lv |
219 |
[GO] |
2020―May―13 |
Decreased T cell populations contribute to the increased severity of COVID-19 |
Rui Liu, Ying Wang, Jie Li, Huan Han, Zunen Xia, Fang Liu, et al. (+4) Kailang Wu, Lan Yang, Xinghui Liu, Chengliang Zhu |
220 |
[GO] |
2020―May―13 |
Dynamic changes in routine blood parameters of a severe COVID-19 case |
Guoguang Lu, Jing Wang |
221 |
[GO] |
2020―May―05 |
Distinct changes in the real-time PCR detectability of certain SARS-CoV-2 target sequences |
András Zóka, Gabriella Bekő |
222 |
[GO] |
2020―Apr―27 |
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study |
Andrea Padoan, Laura Sciacovelli, Daniela Basso, Davide Negrini, Silvia Zuin, Chiara Cosma, et al. (+3) Diego Faggian, Paolo Matricardi, Mario Plebani |
223 |
[GO] |
2020―Apr―27 |
Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis |
Brandon Michael Henry, Jens Vikse, Stefanie Benoit, Emmanuel J. Favaloro, Giuseppe Lippi |
224 |
[GO] |
2020―Apr―24 |
Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China |
Suyu Sun, Xuejiao Cai, Huaguo Wang, Guiqing He, Yin Lin, Bibi Lu, et al. (+3) Chaoyue Chen, Yong Pan, Xingzhong Hu |
225 |
[GO] |
2020―Apr―23 |
Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories |
Takayuki Ishige, Shota Murata, Toshibumi Taniguchi, Akiko Miyabe, Kouichi Kitamura, Kenji Kawasaki, et al. (+3) Motoi Nishimura, Hidetoshi Igari, Kazuyuki Matsushita |
226 |
[GO] |
2020―Apr―22 |
Presepsin in risk stratification of SARS-CoV-2 patients |
Martina Zaninotto, Monica Maria Mion, Chiara Cosma, Daniela Rinaldi, Mario Plebani |
227 |
[GO] |
2020―Apr―18 |
Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients |
Hu Yun, Zhuoran Sun, Jun Wu, Aiguo Tang, Min Hu, Zhongyuan Xiang |
228 |
[GO] |
2020―Mar―28 |
Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient |
Ding-feng Lv, Qi-ming Ying, Yue-song Weng, Chi-bin Shen, Jin-guo Chu, Jing-ping Kong, et al. (+4) Ding-he Sun, Xiang Gao, Xing-bei Weng, Xue-qin Chen |
229 |
[GO] |
2020―Mar―24 |
The host’s angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections |
Joris R Delanghe, Marijn M Speeckaert, Marc L De Buyzere |
230 |
[GO] |
2020―Mar―13 |
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis |
Giuseppe Lippi, Mario Plebani, Brandon Michael Henry |
231 |
[GO] |
2020―Mar―07 |
Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020 |
Rui Liu, Huan Han, Fang Liu, Zhihua Lv, Kailang Wu, Yingle Liu, et al. (+2) Yong Feng, Chengliang Zhu |
232 |
[GO] |
2020―Mar―04 |
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis |
Giuseppe Lippi, Mario Plebani |